Clinical administrators are optimizing their phlebotomy and High Throughput Screening (HTS) to meet constant challenges

Last edited: | Sample Integrity - Back to overview

Healthcare is still reeling from the pandemic, and while many regions have stabilized their HTS performance, it is definitely the beginning of a new era in terms of budget and expenditure. Costs of staff and products are soaring, inflation is volatile, and the economic outlook remains fragile amid a cost of living crisis.

These are the initiatives that clinical administrators have been implementing to deliver and maintain the best care available to their patients, retain their phlebotomy staff, keep labs processing their samples and maintain a culture of safety as a gold standard.

Retaining Staff

Blood collection is currently in need of specialists and technicians across the world. Unlike many professions, technicians are unable to work from home as a lot of lab work cannot be automated [1]. Being a good phlebotomist requires more than just the ability to collect blood, and hospitals are instrumental in attracting, training, and offering pathways for career progression.

Remote working is largely impossible in phlebotomy

Unlike other functions in hospitals, phlebotomy is hands on - whether collecting blood, getting it to the lab, and working with samples within the lab. It cannot be done remotely. It’s a cost that continues to rise and is non-negotiable.

For the staff that remain, the hours are presently long. Advertised vacancies are not being filled and existing, depleted teams need to cover these shifts.

But the roles are valued, and to that end, employers must offer not only secure employment with attractive benefits, they must also offer pathways into the wider or more specialised medical professions.


A steady pipeline of skilled candidates

Gaining hands on training leading to a qualification and a job is vital for replacing sections of the workforce that have either left the profession or are nearing retirement age to ensure sufficient care for an aging population that is requiring healthcare for longer.


Avoiding burnout

Once in the profession, to retain skilled staff requires that existing and new recruits don’t burn out. Burn-out takes considerable time to recover from, and strategies to prevent burnout in healthcare and keeping morale high are equally vital [2].

Administrators and executives recognise the value of their workforce and are investing in their staff because blood collection, for the most part, requires a hands-on interaction between a technician and their patients.

Where can the stresses upon staff and patient be eased

Collection in the community

Collecting blood in the community by trained healthcare personnel eases clinic visit volumes. Having to make repeated hospital visits can take plenty of planning and expense. For patients with limited mobility and other prohibitive circumstances, this service is essential.


Consolidating collection and storage centres

Sample collection depots located at strategically valuable geographic intersections allow for a consolidated approach for sample storage and transport to a processing and analysis facility to support HTS.


Reducing the strain of a patient’s visit, reducing the strain on staff and operating costs

Collecting blood in the hospital and clinics has also been optimised to protect core services. There’s a cost-of-living crisis, parking or transport can be expensive and a visit for the patient may mean missing an entire day off work or having to neglect vital errands. It’s a big expense for patients whose income may have been strained by their illness. It will also cause stress to weakened patients. To address these issues, clinics and hospitals have been implementing the following initiatives:

  • Collection is completed early in the morning to free up a patient’s day
  • Concentrating collection in the morning to lessen the operating costs for a clinic
  • If the patient is receiving attendant treatment/appointments at the same centre; these can be scheduled on the same day

A crisis in blood supply

Blood bank drives have been significantly impacted by the pandemic. Community drives at businesses, schools and collection stations were all curtailed and have not recovered. Clinics are often relying on patients’ relatives to donate blood amid decreased participation from younger generations. Often, there is not enough staff to collect the blood [3].


Critical focuses for research funding, cited in Saillant et al. 2022, include:

  • Optimizing blood banking practices
  • Extending shelf life to avoid product wastage (i.e. cold-stored platelets)
  • Exploring the potential for novel innovations such as synthetic blood component substitutes


Transparency in the health care supply chain manufacturers and their customers, the hospital and clinics, are working together to stabilize costs. Clinical administrators are able to demand a fuller service from their suppliers, not only with product quality, but with vital communication around supply forecasting and costs of product. Rigorous training in product use and customer support has also been expanded to meet demand and offer increased value.

Healthcare will need to be transformed

As expenditure increases, the viability of the present model for healthcare provision is being called into question. The entire model of healthcare is ripe for restructuring, and these will be met by round upon round of optimisations. But right now, the ambition of all hospitals and clinics is to:

  • Maintain the safety of their staff and their patients
  • Maintain their crucial functions


With thanks to Robert E. Del Guidice, Clinical Administrative Director Diagnostic Laboratory Services for the insights that have informed this series of articles.

[1], [2] Deloitte 2023 Global Health Care Outlook

[3] Saillant NN, Kornblith LZ, Moore H, Barrett C, Schreiber MA, Cotton BA, Neal MD, Makar R, Cap AP. The National Blood Shortage-An Impetus for Change. Ann Surg. 2022 Apr 1;275(4):641-643. doi: 10.1097/SLA.0000000000005393. PMID: 35081570; PMCID: PMC9055632.

Safety and value, it’s in our blood

Protecting patients, clinicians and accuracy are topics to be covered in more detail here in the coming months. To ensure you don’t miss out, subscribe to the series here.

Please select your intention and contact the person who is responsible for you!

* required field


This product information is addressed exclusively to healthcare professionals. Devices of Greiner Bio-One are to be used by properly trained healthcare professionals only in accordance with the relevant Instructions for Use (IFU). For a listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use which accompanies each product or is available for download from our website at (Download Center). For more information contact your local Greiner Bio-One sales representative or visit our website. 

All information is provided without guarantee despite careful processing. Any liability, warranty or guarantee of Greiner Bio-One GmbH is excluded. All rights, errors and changes are reserved. If not stated otherwise, Greiner Bio-One GmbH has all copyrights and/or other (user-)rights in this documents, in particular to signs such as the mentioned (word-picture-)brands and logos. Any use, duplication or any other use of the rights of Greiner Bio-One GmbH is expressly prohibited.

Testimonials appearing on this blog communicate their individual experiences regarding the use of our products and/or services. The opinions expressed in this publication are those of the interview partner; they do not purport to reflect the opinions or views of Greiner Bio-One.

This information partly expresses opinions of our customers and/or experiences of individuals and do not purport to reflect the opinions or views of Greiner Bio-One.

Media owner and publisher: Greiner Bio-One GmbH, Bad Haller Str. 32, 4550 Kremsmünster

Sign-up to our newsletter or request more information here
Register now and you will receive our regular Greiner Bio-One News on current topics to stay up-to-date.

We redirected you to your country page. To go back to the previous page, please click the button.

You are not viewing your country page. To switch to your country, please click the button.